³ÉÈËVRÊÓƵ

Urologic Oncology Fellowship

Length: 2 years
Number of positions: 1
Fellowship Directors: Dr Maurice Anidjar and Dr. Simon Tanguay

DEPARTMENT OF SURGERY -DIVISION OF UROLOGY

APPLICATION FORM FOR UROLOGIC ONCOLOGY FELLOWSHIP

Name of Institution: ³ÉÈËVRÊÓƵ -Department of Surgery -Division of Urology
Location: ³ÉÈËVRÊÓƵ Health Centre (MUHC) and Jewish General Hospital (JGH)
Type of Fellowship: Urologic Oncology Fellowship.
Fellowship Directors: Maurice Anidjar, MD; Simon Tanguay, MD

Program Information

• 2-year fellowship position: 50% research, 50% clinical training over a 2-year period.

• Number of fellowship positions requested: one.

• Academic affiliation: ³ÉÈËVRÊÓƵ - Department of Surgery, Division of Urology.

• Hospitals involved in training: ³ÉÈËVRÊÓƵ Health Centre (MUHC) and Jewish General Hospital.

• During the clinical year of the fellowship, the rotations will take place at both sites every 3 months, including 1-month rotation in medical oncology, radiotherapy, surgical pathology and interventional radiology (1 week in each discipline), to enhance the understanding of multidisciplinary care for urologic cancer patients in each site.

• The ³ÉÈËVRÊÓƵ Urologic Oncology Fellowship is designed to train individuals for independent academic careers in urologic oncology, including mini-invasive and robotic-assisted surgical procedures. The clinical training will be complemented by research work over a period of 2 years. AsÌýan exception, in order to suit the individual needs of the applicant, a 1-year clinical and research fellowship could be allowed after common decision of the directors.

ÌýEligibility
Candidates for the ³ÉÈËVRÊÓƵ Urologic Oncology fellowship must be committed to an academic researchÌýcareer in uro-oncology, provide evidence of excellence in academic scholarship and have completedÌýa urology residency program.Ìý Candidates must be fluent in English and/or in French. Candidates must fulfill the general requirements of ³ÉÈËVRÊÓƵ post-graduate fellowship eligibility criteria.

Mission
The main purpose of this fellowship is to train individuals to be innovators and experts in clinical andÌýsurgical practices, research, education and advocacy, a step leading to leadership and being an academic reference in the urologic oncology field.

ÌýThe Clinical Mission
Clinical activities will comprise 50% of the fellowship. During this time, fellows will have exposure to a wide variety of oncologic disease states across a diverse patient population in the 2 Institutions, surrounded by 5 different professors. The fellow will attend and participate to uro-oncology clinicsÌýwith program faculty on a weekly basis. Clinical exposure will allow to integrateinto the initial diagnosis evaluation and treatment processes as well as post-treatment follow-up and disease relapseÌýbe on surgical skills. One of the expertise of ³ÉÈËVRÊÓƵ urology centers is mini-invasive and robotic assisted surgery for radical prostatectomy and partial/radical nephrectomy and specific expertise inÌýradical cystectomy and intraoperative urinary diversion (both ileal conduit and Studerneobladder).

DaVinci robots are in use in each Institution with a double console and simulator at the JGH forÌýtraining purpose.

The fellow will have the opportunity to take part in the major areas of urologic oncology proceduresÌýby open, laparoscopic and robotic techniques. Surgical exposure priority will be given to the PGY4\5

Ìý

Fellow Duties and Responsibilities
The Fellow is responsible for attending weekly clinics related to urologic oncology and willÌýparticipate actively in all aspects of the in-patient clinical service including ward rounds, the consultÌýservice for both site wards and emergency room. He is expected to actively participate in the care andÌýpreparation of patients pre-and post-operatively.

Ìý

The Fellow is expected to contribute to the teaching of residents and students to get knowledge aboutÌýuro-oncologic surgical procedures as well as their indications, outcomes and possible complications,Ìýorganize weekly simulation training sessions on the DaVinci system and participate to the pig lab forÌýmini-invasive procedures.

Ìý

The Fellow will be performing a monthly review of the literature on a urologic oncology subject withÌýpresentation to the ³ÉÈËVRÊÓƵ urology residents under the supervision of a training faculty.

ÌýIn addition, the Fellow will be expected to actively participate in hospital based activities includingÌýSurgical Teaching Rounds, Grand Rounds, Morbidity and Mortality conferences, Tumor Board,Ìýcombined Radiology Urology Rounds and Urology Resident teaching sessions when applicable.ÌýThe Fellow will participate to on-call coverage with residents In addition, research conferences willÌýbe offered in order to enhance the fellow’s understanding of ongoing projects and general researchÌýFellows will attend selected conferences and seminars conducted within the ³ÉÈËVRÊÓƵÌýHealth System to enhance their expertise in clinical oncology, research ethics and responsibility, andÌýknowledge of basic science and clinical research on both sites.

ÌýThe fellow will also participate in the activities of the Rossy Cancer Network GU Site Group Team

Specific objectives include:

• Exposure to complex surgical procedures in uro-oncology.

• Development of advanced skills for mini-invasive/robotic procedures.

• Evaluation and non-surgical management of common complications of uro-oncologic procedures.

• Post-operative care of the patient undergoing uro-oncologic surgery.

• Development of consultant skills for in-hospital patients.

• Exposure to diagnostic cystoscopy.

• Knowledge on the indications and interpretation of radiologic investigations, namely prostateÌýmagnetic resonance imaging, exposure to MR-targeted prostate TRUS biopsy and focal therapyÌýfor prostate cancer, renal biopsy and needle ablation of small renal masses, organ/tumor US/CT guided biopsy.

• Protecting fifteen percent of the total curriculum for clinical research activities, the Fellow willÌýhave opportunities to develop projects involving education, performance measurements and clinicaloutcomes in urologic oncology that will be attested by peer-reviewed publications andÌýcommunications to QUA, CUA and/or international meetings.

ÌýProgram Faculty

Teaching staff include

Urologic Oncology

JGH: Dr Victor McPherson, M.D.ÌýMaurice Anidjar, M.D., PhD

MUHC: Simon Tanguay, M.D.;ÌýArmen Aprikian, M.D.;ÌýWassim Kassouf, M.D., Dr Rafael Sanchez Salas, M.D.

Medical Oncology Radiation Oncology

JGH: Michael Pollak, M.D., PhD, Tamin Niazi, M.D.;ÌýCristiano Ferrario, M.D., Boris Bahoric, M.D.;ÌýWilson Miller, M.D., PhD

MUHC:Ìý Fabio Cury, M.D.;Ìý Sergio Faria, M.D., Dr Ragu Rajan, M.D., Dr Ramy Saleh, M.D., Luis Souhami, M.D.

Genitourinary Pathology

JGH: Mona ElAdim, M.D.;ÌýAdrian Gologan, M.D.

MUHC: FadiBrimo, M.D.

Ìý

Summary of clinical practice:
The clinical practice at the JGH focuses on robot-assisted procedures in urologic cancers, fromÌýradical prostatectomy, complex partial nephrectomy to radical cystectomy with intra-operativeÌýurinary diversion, bothileal conduit and ilealneobladder, to RPLND for testis cancer in selectedÌýprostate biopsy and focal HIFU ablation of prostate cancer. The clinical practice at MUHC focusesÌýon robotic radical prostatectomy, open and robotic partial nephrectomy, laparoscopic radicalÌýnephrectomy, radical cystectomy with various diversions, open RPLND and major complex cases. ÌýMajor strengths:The teaching faculty is widely and internationally recognized for its excellence in theÌýfield of urologic oncology and minimally invasive surgery from both a clinical and researchÌýsufficient exposure to the surgical cases. The academic program is well organized and interactionÌýwith surgeons, researchers, fellows, residents and students is very stimulating.

Roles of Teaching Faculty
Assess and instruct the fellow of relevant information to clinical practice and also assess:

-The fellow's clinical judgment, diagnostic and therapeutic skills;

-The fellow's surgical skills in order to perform an efficient and safe open, laparoscopic and robotic

procedure in complex cases;

-The fellow's capacity to consult with other physicians and allied health professionals,

-The fellow's contribution to effectively improve residents' knowledge in urologic oncology.

Surgical Volume
Yearly number of urologic oncology procedures at the 2 ³ÉÈËVRÊÓƵ institutions in 2012-2013-2014

The Research Mission
³ÉÈËVRÊÓƵ offers outstanding basic science and clinical research opportunities for fellows inÌýurologic oncology, mainly in prostate, kidney and bladder cancer. The research experience is tailoredÌýto the previous experience and future interests of each applicant.

Research Program Options
Clinical/Health Services and Quality of Care Research in uro-oncology.ÌýResearch Fellow will design at least one high value clinical or health services research endeavor, andÌýwill be expected to initiate, complete and report in a peer-reviewed journal an independent clinicalÌýresearch project. ³ÉÈËVRÊÓƵ urology centers houses national data repositories as well as local IRB approved clinical databases that details prostate cancer, bladder cancer and renal cancer.

Basic Translational Research in uro-oncology.

Several active basic science laboratories are welcoming Research Fellows in urologic oncology onÌýboth sites, at the MUHC Research Center and at the Lady Davis Research Institute at JGH. ProstateÌýand bladder cancer are the main foci of basic science research in both sites. The program is intendedÌýto equip select physicians at the post-doctoral level with the necessary tools to pursue an independentÌýresearch career in the field of urologic oncology. The program could also be adapted to ResearchÌýFellow at the PhD level. At the completion of the research program over the 2-year fellowship,Ìýtrainees will have the skills to : 1- formulate testable hypotheses focused on important questions orÌýproblems in urologic oncology ; 2- develop laboratory-based skills to adequately test theseÌýhypotheses, and 3- develop critical thinking skills required to interpret and analyze quantitativeÌýlaboratory data. Training in grant-writing techniques, presentation skills for optimal verbal andÌýwritten communication of research findings will be part of the training. The trainee will be exposedÌýto research seminars and expert presentations on both sites.

Basic/Translational Laboratories

LDI basic science laboratories: Dr Mark Trifiro, Dr Wilson Miller, Dr Michael Pollak, Dr AlanÌýSpatz

MUHC basic science laboratories: Dr Simone Chevalier, Dr. Jacques Lapointe, David Labbé

MUHC Epidemiology and Health Outcomes: Dr. Alice Dragomir

The Education Mission

During the 2-year rotation throughout their clinical and research components, Fellows will integrateÌýfoundational concepts in clinical teaching. The goal here is to provide the education tools for ourÌýFellows to be effective and thoughtful educators in their academic careers. Specific techniques andÌýtools in clinical education will help them to teach in the operating room and they will be advised toÌýattend teaching seminars at ³ÉÈËVRÊÓƵ.We hope this will prepare our Fellows to meet theirÌýupcoming obligations as teachers and allow them to be distinguished clinician surgeons, researchersÌýand educators.